Inspire Medical Systems, Inc. (INSP) Net margin 2016–2025
Inspire Medical Systems, Inc. (INSP) net profit margin by fiscal year — reported net income divided by reported revenue.
15.9%FY2025 · since FY2016: -112.8% → 15.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 15.9% | +9.3 pp |
| FY2024 | 6.7% | +10.1 pp |
| FY2023 | -3.4% | +7.6 pp |
| FY2022 | -11.0% | +7.0 pp |
| FY2021 | -18.0% | +31.6 pp |
| FY2020 | -49.6% | -9.1 pp |
| FY2019 | -40.5% | +2.6 pp |
| FY2018 | -43.1% | +18.2 pp |
| FY2017 | -61.3% | +51.5 pp |
| FY2016 | -112.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More INSP financial trends
INSP RevenueINSP Net incomeINSP Gross profitINSP Gross marginINSP Operating incomeINSP Operating marginINSP Operating cash flowINSP Free cash flowINSP Capital expendituresINSP Return on equityINSP Stock buybacksINSP Dividends paidINSP Total assetsINSP Total liabilitiesINSP Shareholders’ equityINSP overview →